A high-throughput soft agar assay for identification of anticancer compound

Area of Science:

• Oncology
• Drug Discovery
• Cell Biology

Background:

• Traditional monolayer assays have limitations in identifying novel anticancer compounds.
• Cell transformation assays can be adapted for drug discovery.
• Anchorage-independent cell proliferation is a key indicator of transformation and potential anticancer drug targets.

Purpose of the Study:

• To develop and validate a 384-well soft agar assay for identifying novel anticancer compounds.
• To quantitate cell proliferation in a 3-dimensional (3-D) anchorage-independent format.
• To compare the efficacy of the novel assay against traditional monolayer formats.

Main Methods:

• A 384-well soft agar assay was developed using HCC827 cells.
• The assay quantitates cell proliferation in a 3-D anchorage-independent format.
• A set of 9600 compounds was used to validate the assay, with results compared to a monolayer assay.

Main Results:

• The soft agar assay successfully quantitated cell proliferation in a 3-D format.
• The assay demonstrated robustness in identifying potential anticancer compounds.
• Results indicated that the 3-D assay could identify compounds missed by monolayer formats.

Conclusions:

• The developed soft agar assay is a robust method for discovering novel anticancer compounds.
• This 3-D assay format offers advantages over traditional monolayer assays.
• The assay has the potential to improve the identification of effective anticancer therapeutics.